Cargando…

Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency

Esophageal cancer is a cancer with poor prognosis and the standard 1(st) line treatment for metastatic or recurrent EC is systemic chemotherapy with doublet chemotherapy based on platinum and 5-fluorouracil (5-FU). However, 5-FU could be a source of severe treatment-related toxicities due to deficie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, Antonin, Royer, Bernard, Boidot, Romain, Berthier, Joseph, Ghiringhelli, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319454/ https://www.ncbi.nlm.nih.gov/pubmed/37409256 http://dx.doi.org/10.3389/fonc.2023.1187052

Ejemplares similares

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
por: van Staveren, Maurice C., et al.
Publicado: (2011)

Delayed Presentation of DPD Deficiency in Colorectal Cancer
por: Law, Lindsey, et al.
Publicado: (2014)

Study of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) Expressions on 5-Fluorouracil in Oral Squamous Cell Carcinoma
por: Akhter, Khaleda, et al.
Publicado: (2019)

Immune effects of 5-fluorouracil: Ambivalence matters
por: Ghiringhelli, François, et al.
Publicado: (2013)

Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping
por: Royer, B., et al.
Publicado: (2023)

Transcriptome analysis of T(H)2 CD4(+) T cells differentiated from wild-type and NLRP3KO mice
por: Bruchard, Mélanie, et al.
Publicado: (2015)

EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma
por: Richard, Corentin, et al.
Publicado: (2018)

Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life
por: Dalens, Lorraine, et al.
Publicado: (2022)

A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer
por: Marin, Clémence, et al.
Publicado: (2020)

Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis
por: Laures, Nicolas, et al.
Publicado: (2022)

Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma
por: Kim, Stefano, et al.
Publicado: (2022)

Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
por: Ghiringhelli, Francois, et al.
Publicado: (2016)

Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022)

Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity
por: Wu, Kathie, et al.
Publicado: (2023)

Simulation of tetraetherlipids on solid surfaces – an extension of the DPD-model
por: Engels, Christoph, et al.
Publicado: (2008)

DPD status and fluoropyrimidines-based treatment: high activity matters too
por: Chamorey, Emmanuel, et al.
Publicado: (2020)

Spindle Cell Squamous Cell Carcinoma of the Scalp Treated With Pembrolizumab Cisplatin and 5-Fluorouracil
por: Alzahrani, Ali M, et al.
Publicado: (2021)

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients
por: Callon, Sidonie, et al.
Publicado: (2023)

5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo
por: Cheng, Mingrong, et al.
Publicado: (2022)

ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway
por: Gu, Jinrong, et al.
Publicado: (2022)

Disphosphonates cardiac uptake in familial amyloid neuropathy: Comparison between DPD and HMDP
por: Regaieg, Hamza, et al.
Publicado: (2015)

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker
por: Scully, Paul R., et al.
Publicado: (2020)

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature
por: White, Cassandra, et al.
Publicado: (2021)

A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab
por: Kanamaru, Tomohiro, et al.
Publicado: (2014)

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary
por: Suzuki, Risako, et al.
Publicado: (2023)

Restoring HOXD10 Exhibits Therapeutic Potential for Ameliorating Malignant Progression and 5-Fluorouracil Resistance in Colorectal Cancer
por: Pan, Weijie, et al.
Publicado: (2021)

Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis
por: Wang, Ya, et al.
Publicado: (2021)

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer
por: Zhang, Yu, et al.
Publicado: (2022)

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
por: Hervé, Laure, et al.
Publicado: (2022)

The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia
por: Wang, Lu, et al.
Publicado: (2023)

PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
por: Tharin, Zoé, et al.
Publicado: (2023)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hanemaaijer, Saskia H., et al.
Publicado: (2020)

Scaling and Interactions of Linear and Ring Polymer Brushes via DPD Simulations
por: Jehser, Martin, et al.
Publicado: (2019)

DPD Simulation on the Transformation and Stability of O/W and W/O Microemulsions
por: Li, Menghua, et al.
Publicado: (2022)

HOXA13, Negatively Regulated by miR-139-5p, Decreases the Sensitivity of Gastric Cancer to 5-Fluorouracil Possibly by Targeting ABCC4
por: Chen, Zhengqian, et al.
Publicado: (2021)

Multi-modality imaging in cardiac ATTR amyloidosis: agreement between echocardiography, MRI and DPD-scintigraphy
por: Eliahou, Ludivine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g548eqpq7qcar80otdbh5d8hpp